An international team led by Justin Reese, a research scientist in the Environmental Genomics and Systems Biology (EGSB) Division, analyzed electronic health record data aggregated in the National COVID Cohort Collaborative (N3C) Data Enclave to assess whether metformin is associated with reduced COVID-19 severity in people with prediabetes or polycystic ovary syndrome (PCOS), two common conditions that increase the risk of severe COVID-19 presentation.
In Cell Genomics, an international consortium led by researchers at the Joint Genome Institute team generated 824 new Actinobacteria genomes, which were were combined with nearly 5,000 publicly available ones and 1,100 metagenome-assembled genomes (MAGs) reconstructed from sequenced environmental samples in a previous study.
A team headed by the Environmental Genomics and Systems Biology (EGSB) Division’s Chris Mungall, will be part of the National Institute of Health program, Bridge to Artificial Intelligence (Bridge2AI). Mungall and his colleagues will be collaborators in the Standards Core, led by the University of Colorado.
Each year, the Berkeley Lab Director’s Achievement Award program recognizes outstanding contributions by employees to all facets of Lab activities. Several Biosciences Area personnel are among the 2022 honorees.
A team led by UC Berkeley’s Jill Banfield discovered DNA structures within a methane-consuming microbe that appear to supercharge the organism’s metabolic rate. In a nod to the Star Trek universe, they named the genetic elements “Borgs” because the DNA within contains genes assimilated from many organisms.